Reduced brain Na+, K+-ATPase activity in rats with galactosamine-induced hepatic failure: relationship to encephalopathy and cerebral oedema.

Previously we have shown that sera from patients with fulminant hepatic failure (FHF) will inhibit partially purified rat brain Na+, K+-ATPase and sodium efflux from human leucocytes in vitro. Similar inhibition may be involved in the pathogenesis of encephalopathy and cerebral oedema in these patients. In the present study we have attempted to establish whether the activity of brain Na+, K+-ATPase is decreased in vivo in rats with D-galactosamine induced hepatic failure using homogenates of snap-frozen brains. Na+, K+-ATPase activity was significantly reduced in the forebrain region at the stage of mild encephalopathy (43 h after injection), while at the deeper stage of coma (43-53 h after injection) enzyme activity was further reduced in the forebrain region and was also significantly reduced in the hindbrain region. Ouabain insensitive ATPase activity was not significantly altered at any time. While a significant increase in the water content (0.5%) of the hindbrain region was found 43 h after galactosamine, there was no clear correlation between the development of cerebral oedema and the reduction of Na+, K+-ATPase activity. The activity of partially purified normal rat brain Na+, K+-ATPase was 15% lower when incubated with sera from rats in the deep stage of coma compared with control sera. These data support other evidence that the reduction in brain Na+, K+-ATPase is likely to be due to toxic substance circulating in serum which have been shown to inhibit this enzyme in vitro and to cause coma when administered to normal animals.

[1]  L. Zieve,et al.  Brain methanethiol and ammonia concentrations in experimental hepatic coma and coma induced by injections of various combinations of these substances. , 1984, The Journal of laboratory and clinical medicine.

[2]  R. Ede,et al.  Experimental Studies of Blood Brain Barrier Permeability in Acute Hepatic Failure , 1984, Hepatology.

[3]  R. Hughes,et al.  Removal of inhibitors of brain Na+, K+-ATPase by hemoperfusion in fulminant hepatic failure. , 1984, Artificial organs.

[4]  R. Hughes,et al.  Inhibition of partially purified rat brain Na+, K+-dependent ATPase by bile acids, phenolic acids and endotoxin. , 1984, Clinical science.

[5]  P. Munson,et al.  Changes in the Status of Neurotransmitter Receptors in a Rabbit Model of Hepatic Encephalopathy , 1984, Hepatology.

[6]  L. Poston,et al.  Effects of serum from patients with fulminant hepatic failure on leucocyte sodium transport. , 1982, Clinical science.

[7]  S. Bloom,et al.  The gut hormone profile of fulminant hepatic failure. , 1981, The American journal of gastroenterology.

[8]  J. S. Owen,et al.  Decreased erythrocyte membrane fluidity and altered lipid composition in human liver disease. , 1981, Journal of lipid research.

[9]  J. Harding,et al.  The Na+,K+ ‐ATPase: A Plausible Trigger for Voltage‐Independent Release of Cytoplasmic Neurotransmitters , 1981, Journal of neurochemistry.

[10]  K. Sweadner Two molecular forms of (Na+ + K+)-stimulated ATPase in brain. Separation, and difference in affinity for strophanthidin. , 1979, The Journal of biological chemistry.

[11]  L. Poston,et al.  A study in vitro of the sodium pump in fulminant hepatic failure. , 1978, Clinical science and molecular medicine.

[12]  C. Goresky,et al.  Changes in the blood-brain barrier in hepatic coma after hepatectomy in the rat. , 1977, Gastroenterology.

[13]  L. Zieve,et al.  Action of methanethiol on membrane (Na+ , K+)-ATPase of rat brain. , 1976, Biochemical pharmacology.

[14]  R. Thomas,et al.  Electrogenic sodium pump in nerve and muscle cells. , 1972, Physiological reviews.

[15]  P. Trinder Determination of Glucose in Blood Using Glucose Oxidase with an Alternative Oxygen Acceptor , 1969 .

[16]  松下 雪郎 Folin phenol Reagentの呈色反応について-続- , 1967 .

[17]  R. Hughes,et al.  Inhibition of Rat Brain Na+,K+−ATPase Activity by Serum from Patients with Fulminant Hepatic Failure , 1984, Hepatology.

[18]  R. Bais A rapid and sensitive radiometric assay for adenosine triphosphatase activity using Cerenkov radiation. , 1975, Analytical biochemistry.

[19]  T. Clausen Measurement of 32P activity in a liquid scintillation counter without the use of scintillator. , 1968, Analytical biochemistry.

[20]  D. Dahl Short chain fatty acid inhibition of rat brain Na-K adenosine triphosphatase. , 1968, Journal of neurochemistry.

[21]  I. Klatzo,et al.  Presidental address. Neuropathological aspects of brain edema. , 1967, Journal of neuropathology and experimental neurology.